Adamis Pharmaceuticals Corporation Gains 77.64%
Wed, Jan 20, 2021 at 05:30 PM
Adamis Pharmaceuticals Corporation (ADMP:NASDAQ) jumped higher at $1.43, representing a gain of 77.6%. On Tue 19 Jan 21, ADMP:NASDAQ hit a New 2-Week Intraday High of $0.84. The stock got featured on our News Catalysts scanner on Wed 20 Jan 21 at 01:48 PM in the 'BIOTECH' category. From Tue 05 Jan 21, the stock recorded 77.78% Up Days and 70.00% Green Days
The stock spiked on Wed 29 Jul 20 at $1.51 with a volume of 48M+, and its share price has been moving sideways in recent weeks.
About Adamis Pharmaceuticals Corporation (ADMP:NASDAQ)
Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company that develops & commercializes products in the therapeutic areas of respiratory disease & allergy. Its products include Epinephrine Injection PFS syringe, APC-1000, APC-2000, & APC-5000.
Top 10 Gainers:
- Obalon Therapeutics, Inc. (OBLN:NASDAQ), 414.29%
- Steel Connect, Inc. (STCN:NASDAQ), 79.19%
- Adamis Pharmaceuticals Corporation (ADMP:NASDAQ), 77.64%
- Caladrius Biosciences, Inc. (CLBS:NASDAQ), 77.3%
- Cancer Genetics, Inc. (CGIX:NASDAQ), 74.93%
- 36Kr Holdings Inc. (KRKR:NASDAQ), 74.92%
- Titan Medical Inc. (TMDI:NASDAQ), 52.41%
- Tiziana Life Sciences PLC (TLSA:NASDAQ), 49.21%
- Globalstar, Inc. (GSAT:NYSEMKT), 48.59%
- YQ (YQ:NASDAQ), 48.24%